Premarket Losers as of 9:05 am (6/7/2018)

|By:, SA News Editor

MDXG -32% after restating financial statements and announcing new appointments.

PTI -29% on announcing data from ongoing Phase 1 Study of PTI-801 in cystic fibrosis patients.

REVG -20% on Q2 earnings.

SJM -8% on Q4 earnings.

I -7%.

FGP -6% on Q3 earnings.

CLDR -5% on Q1 earnings.

ANW -5%.

THO -5% on Q3 earnings.

VBLT -5%.

Subscribe for full text news in your inbox